Holen Sie sich die Stockscreener-App
0.6565
0.58%
0.0038
Vorhandelsmarkt:
.66
0.0035
+0.53%
Bnb Plus Corp Aktie (BNBX) Neueste Nachrichten
BNB Plus Corp. (UDJ1.F) Income Statement - Yahoo! Finance Canada
Director at BNB PLUS CORP. (BNBX) granted 77,038 incentive stock options at $0.69 - stocktitan.net
Director at BNB Plus (BNBX) awarded 77,038 incentive stock options - stocktitan.net
[Form 4] BNB PLUS CORP. Insider Trading Activity - stocktitan.net
BNB Plus (NASDAQ: BNBX) director awarded 77,038-share stock option - stocktitan.net
BNB PLUS (BNBX) chairman Joshua Kruger receives options on 77,038 shares - stocktitan.net
BNB PLUS (NASDAQ: BNBX) director receives grant of 77,038 stock options at $0.69 - stocktitan.net
BNBX Stock Price, Quote & Chart | BNB PLUS CORP (NASDAQ:BNBX) - ChartMill
BNB Plus Faces Nasdaq Delisting Risk After Bid Price Breach - The Globe and Mail
Comstock MultiChain Fund, L P Engages with BNB Plus Corp - MarketScreener
BNB Plus Corp. receives Nasdaq delisting notice for bid price non-compliance - Investing.com India
Comstock fund reports 9.9% BNB Plus (BNBX) ownership and warrant stake - Stock Titan
Richard L. Shorten Discloses Investment at BNB Plus Corp. with 9.99% Stake - TradingView
BNB Plus Received Notice of Delisting - TradingView
BNB Plus (NASDAQ: BNBX) faces Nasdaq delisting risk after $1 bid price breach - Stock Titan
If You Invested $1,000 in Applied Dna Scie (APDN) - stocktitan.net
BNB Plus Corp.: Fundamental Analysis and Financial Ratings | UDJ1 | US03815U6073 - marketscreener.com
BNBX Subsidiary Gains Patent For Enhanced RNA Synthesis - blockzeit.com
BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform - EIN News
BNB Plus lands EU patent on enzyme to speed mRNA drug output - Stock Titan
BNBX | BNB Plus Corp. Common Institutional Ownership - Quiver Quantitative
BNBX | BNB Plus Corp. Common Stock Data, Price & News - Quiver Quantitative
CEA Industries Appoints Brent Miller as Chief Financial Officer - GlobeNewswire
APDN SEC FilingsApplied Dna Scie 10-K, 10-Q, 8-K Forms - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BNBX Earnings History & Surprises | EPS & Revenue Results | BNB PLUS CORP (NASDAQ:BNBX) - ChartMill
MDJM Ltd (UOKA) - MSN
Crypto Currents: Meta plans entry into stablecoin space - TipRanks
BNBX Should I Buy - Intellectia AI
Capital One Financial Corp Stock Moved Up by 4.72% on Feb 25: Drivers Behind the Movement - TradingKey
BNB Plus’ Biopharma subsidiary LineaRx lands major LineaDNA orders - Indian Pharma Post
AVI Open Letter to HVPE Board, Manager, Shareholders - Foster's Daily Democrat
BNB Plus Corp. receives two new orders for LineaDNA - TipRanks
BNB Plus Corp. (BNBX) Reports New Orders for LineaDNA, Targets C - GuruFocus
BNBX Highlights Strategic BNB Token Holdings Amid Portfolio Upda - GuruFocus
BNB Plus Corp. reports BNB token holdings valued at $10.7M as of February 23 - TipRanks
BNB Plus holds over $10.7M in BNB tokens, above its market cap - Stock Titan
DL Holdings Group Ltd (1709) - MSN
Roxmore Resources Inc (RM) - MSN
Blackstone Inc (BX) Stock, Price, News, Quotes, Forecast and Insights - MSN
Paladin Energy Ltd (PDN) - MSN
MSN Money - MSN
Director James Haft discloses 22,590 BNB PLUS (BNBX) shares on Form 3 - Stock Titan
OBOOK Holdings (OWLS) and BNB Plus Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index
BNB Plus: Fiscal Q1 Earnings Snapshot - kens5.com
BNB Plus: Overview of First Fiscal Quarter Financial Results - Bitget
BNB PLUS CORP. SEC 10-Q Report - TradingView
BNBX: Net loss surged on lower revenue and one-time digital asset strategy expenses - TradingView
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
0.59%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):